Castle Biosciences, Inc. (CSTL)
NASDAQ · Healthcare
Castle Biosciences, Inc. Long Term Debt 2018–2025
Castle Biosciences, Inc. annual long term debt history from 2018 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Castle Biosciences, Inc. long term debt as of December 31, 2025: 10.1M, a 0.34% increase year-over-year.
- Castle Biosciences, Inc. long term debt for 2025 were 10.1M, a 0.34% increase from 2024.
- Castle Biosciences, Inc. long term debt for 2024 were 10.0M, a 62.44% decrease from 2019.
- Castle Biosciences, Inc. long term debt for 2019 were 26.7M, a 8.93% increase from 2018.
- Castle Biosciences, Inc. long term debt for 2018 were 24.5M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Castle Biosciences, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $10 |
| 2024 | $10 |
| 2019 | $27 |
| 2018 | $25 |
Castle Biosciences, Inc. Long Term Debt — FAQ
Castle Biosciences, Inc. (CSTL) long term debt over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CSTL's long term debt history?
The chart and table above show Castle Biosciences, Inc.'s long term debt by year and by quarter, including the growth rate.